Capital Analysts LLC’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.3K Buy
+560
New +$10.1K ﹤0.01% 1280

Other funds holding AMRX

Capital Analysts LLC's AMRX Position: Q3 2026 in Review

Capital Analysts LLC opened a new position in Amneal Pharmaceuticals (AMRX) in Q3 2026: 560 shares worth $11.3K. The stake represents ﹤0.01% of the portfolio and ranks #1280 among its holdings.

334 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • Capital Analysts LLC held 560 shares of Amneal Pharmaceuticals worth $11.3K as of Q3 2026.
  • Amneal Pharmaceuticals was a new Capital Analysts LLC position in Q3 2026.
  • Amneal Pharmaceuticals made up ﹤0.01% of Capital Analysts LLC's portfolio in Q3 2026, its #1280 holding.
  • 334 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on Capital Analysts LLC's 13F filing for Q3 2026, filed 13 Nov 2026.